Literature DB >> 20691134

Genetic variation of the FADS1 FADS2 gene cluster and n-6 PUFA composition in erythrocyte membranes in the European Prospective Investigation into Cancer and Nutrition-Potsdam study.

Vera Zietemann1, Janine Kröger, Cornelia Enzenbach, Eugene Jansen, Andreas Fritsche, Cornelia Weikert, Heiner Boeing, Matthias B Schulze.   

Abstract

Delta-5 (D5D) and delta-6 (D6D) desaturases are key enzymes in PUFA metabolism. Several factors (e.g. hyperglycaemia, hypertension, blood lipids, statins and fatty acids in diet and biological tissues) may influence desaturase activity. The goals were to evaluate the associations between variation in genes encoding these desaturases (FADS1 and FADS2) and blood concentrations of n-6 PUFA and estimated D5D and D6D activities (evaluated as product/precursor ratio), and to investigate whether other factors influencing the activity of desaturases modify these associations. A random sample of 2066 participants from the European Prospective Investigation into Cancer and Nutrition-Potsdam study (n 27 548) was utilised in the analyses. Crude and adjusted associations between rs174546 genotypes (reflecting genetic variation in the FADS1 FADS2 gene cluster), n-6 PUFA in erythrocytes and estimated desaturase activities were evaluated using multiple linear regression. Potential effect modification was determined by performing stratified analyses and evaluating interaction terms. We found rs174546 genotypes to be related to linoleic (r² 0·060), γ-linolenic (r² 0·041), eicosadienoic (r² 0·034), arachidonic (r² 0·026), docosatetraenoic acids (r² 0·028), estimated D6D activity (r² 0·052) and particularly strongly to dihomo-γ-linolenic acid (DGLA, r² 0·182) and D5D activity (r² 0·231). We did not observe effect modifications with regard to the estimated D5D activity, DGLA and arachidonic acid (AA) for most of the factors evaluated; however, the genetic effect on D5D activity and DGLA may be modified by the dietary n-6:n-3-ratio (P-values for interaction: 0·008 and 0·002), and the genetic effect on DGLA and AA may be modified by lipid-lowering medication (P-values for interaction: 0·0004 and 0·006). In conclusion, genetic variation in the FADS1 FADS2 gene cluster affects n-6 PUFA profiles in erythrocytes reflecting altered D5D activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691134     DOI: 10.1017/S0007114510002916

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  24 in total

1.  Plasma fatty acids as predictors of glycaemia and type 2 diabetes.

Authors:  Maria A Lankinen; Alena Stančáková; Matti Uusitupa; Jyrki Ågren; Jussi Pihlajamäki; Johanna Kuusisto; Ursula Schwab; Markku Laakso
Journal:  Diabetologia       Date:  2015-08-16       Impact factor: 10.122

Review 2.  Polyunsaturated fatty acid metabolism in prostate cancer.

Authors:  Isabelle M Berquin; Iris J Edwards; Steven J Kridel; Yong Q Chen
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

3.  Association between erythrocyte membrane fatty acids and biomarkers of dyslipidemia in the EPIC-Potsdam study.

Authors:  S Jacobs; K Schiller; E Jansen; A Fritsche; C Weikert; R di Giuseppe; H Boeing; M B Schulze; J Kröger
Journal:  Eur J Clin Nutr       Date:  2014-02-26       Impact factor: 4.016

4.  Endogenous Production of Long-Chain Polyunsaturated Fatty Acids and Metabolic Disease Risk.

Authors:  Harvey J Murff; Todd L Edwards
Journal:  Curr Cardiovasc Risk Rep       Date:  2014-12-01

5.  Genetic variation at the FADS1-FADS2 gene locus influences delta-5 desaturase activity and LC-PUFA proportions after fish oil supplement.

Authors:  Maryam Al-Hilal; Aseel Alsaleh; Zoitsa Maniou; Fiona J Lewis; Wendy L Hall; Thomas A B Sanders; Sandra D O'Dell
Journal:  J Lipid Res       Date:  2012-11-15       Impact factor: 5.922

6.  Can polymorphisms in the fatty acid desaturase (FADS) gene cluster alter the effects of fish oil supplementation on plasma and erythrocyte fatty acid profiles? An exploratory study.

Authors:  Suzanne J Meldrum; Yuchun Li; Guicheng Zhang; Alexandra E M Heaton; Nina D'Vaz; Judith Manz; Eva Reischl; Berthold V Koletzko; Susan L Prescott; Karen Simmer
Journal:  Eur J Nutr       Date:  2017-09-19       Impact factor: 5.614

7.  Interaction between a common variant in FADS1 and erythrocyte polyunsaturated fatty acids on lipid profile in Chinese Hans.

Authors:  Jingwen Zhu; Qi Sun; Geng Zong; Yuan Si; Chen Liu; Qibin Qi; Xingwang Ye; Liang Sun; Hongguang Sheng; Huaixing Li; Xu Lin
Journal:  J Lipid Res       Date:  2013-02-08       Impact factor: 5.922

8.  Genetic predisposition scores for dyslipidaemia influence plasma lipid concentrations at baseline, but not the changes after controlled intake of n-3 polyunsaturated fatty acids.

Authors:  Aseel AlSaleh; Zoitsa Maniou; Fiona J Lewis; Wendy L Hall; Thomas A B Sanders; Sandra D O'Dell
Journal:  Genes Nutr       Date:  2014-06-03       Impact factor: 5.523

9.  Genetic adaptation of fatty-acid metabolism: a human-specific haplotype increasing the biosynthesis of long-chain omega-3 and omega-6 fatty acids.

Authors:  Adam Ameur; Stefan Enroth; Asa Johansson; Ghazal Zaboli; Wilmar Igl; Anna C V Johansson; Manuel A Rivas; Mark J Daly; Gerd Schmitz; Andrew A Hicks; Thomas Meitinger; Lars Feuk; Cornelia van Duijn; Ben Oostra; Peter P Pramstaller; Igor Rudan; Alan F Wright; James F Wilson; Harry Campbell; Ulf Gyllensten
Journal:  Am J Hum Genet       Date:  2012-04-12       Impact factor: 11.025

10.  Polyunsaturated fatty acid levels in blood during pregnancy, at birth and at 7 years: their associations with two common FADS2 polymorphisms.

Authors:  Colin D Steer; Joseph R Hibbeln; Jean Golding; George Davey Smith
Journal:  Hum Mol Genet       Date:  2011-12-21       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.